by Amy Berger | Feb 12, 2025 | Blog, News
Per New Guidance – COVID-19 Research Now Under BSL-2, Offering Cost-Effective Solutions at IITRI We are pleased to announce that recent updates from the CDC and NIH now permit handling SARS-CoV-2 under Biosafety Level 2 (BSL-2) conditions for specific...
by Amy Berger | Feb 4, 2025 | Blog
The Importance of CRO Experience and Capabilities in Cancer Research On this World Cancer Day, we celebrate the remarkable progress made in the fight against cancer and the crucial role that contract research organizations (CROs) like IITRI play in this global effort....
by Amy Berger | Dec 10, 2024 | News, Publications and Press
Check Out Recent IITRI Mentions and Co-authored Publications Below! NPJ Vaccines Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines Published Nov 19, 2024. MDPI Vaccines Intranasal M2SR and BM2SR Vaccine...
by Amy Berger | Sep 11, 2024 | Events, News
Our team will be in Austin for the American College of Toxicology Meeting and Expo Live! this November! You can find our team in the exhibit hall at Booth 406 near the entrance. We look forward to speaking with everyone there! Drop us a line if you’d like to set up a...
by Amy Berger | Jul 24, 2024 | Blog, Events, News
MEET WITH OUR TEAM IN DC! We are excited to announce our participation in the Inaugural General Membership Meeting for the BARDA Rapid Response Partnership Vehicle (RRPV) consortium in Washington, D.C., on August 13-14. We will be presenting a poster and participating...
Recent Comments